Year-over-year earnings per share growth for the last twelve months: NexImmune, Inc. (NEXI)

neximmune.com (NEXI) - corporate logo

The development of NexImmune, Inc. (NEXI) relies on the validation of T-cell efficacy and interest from pharmaceutical behemoths. The quarterly EPS growth rate shows a sharp decline, driven by a loss of operational activity and the depletion of remaining capital. Previously, the AIM platform established patent protection via nanostructures, but currently, the value of 0.00 reflects the metric level amid a complete business restructuring.

NexImmune Inc (NEXI) Year-over-year net earnings per share growth for the last 12 months: for the period 07/04/2022 - 08/04/2024

Comprehensive metric breakdowns and analytics for neximmune.com (NEXI)

- share price and expert price forecast:
Stock Price NexImmune Corporation|NEXI - Analyst Median Target
- company stock exchange capitalization indicators:
Market Value NexImmune, Inc.|NEXI - Real Price to Acquire Entire Company
- book capitalization data:
Net Assets per Single Share NexImmune|NEXI - Company Net Assets|Market Cap to Net Assets Ratio neximmune.com|NEXI - Company Total Assets
- debt and liquidity details:
Debt to Equity NexImmune, Inc.|NEXI - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity NexImmune Corporation|NEXI - Company Cumulative Debt|Debt to Book Value NexImmune|NEXI - Long-Term Indebtedness|Company Current Liabilities NexImmune|Quick Ratio neximmune.com
- earnings and market multiples details:
NEXI - Final Profit|Projected Future Earnings NexImmune, Inc.|NEXI - Market Cap to Earnings|Future Price to Earnings NexImmune, Inc.|NEXI - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple NexImmune Corporation|NEXI - Operating profit EBITDA|Earnings per share for the last twelve months NexImmune|NEXI - Earnings per one share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months neximmune.com|NEXI - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year NexImmune, Inc.
- revenue and sales proceeds data:
NEXI - Company Sales Volume|Projected Sales Volume neximmune.com|NEXI - Price to Sales|Forward Price-to-Revenue Multiple NexImmune Inc|NEXI - Sales Growth YoY (Last 12 Months)
Comprehensive company analysis:NexImmune Inc, NEXI
Manufactured product of NexImmune, Inc.

NexImmune, Inc. (NEXI) is advancing pharmaceutical developments amidst geopolitical risks impacting supply chains and patent protection. Analyzing the current quarterly EPS pace allows for an assessment of net income per share dynamics based on 10-Q reports, excluding random spikes; such a smoothed revenue trajectory is critical for distinguishing sustainable growth from temporary factors, preventing investment in weak assets.

Competitors of NexImmune, Inc.

IBRX: Quarterly EPS earnings growth|IMCR - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months januxrx.com|Year-over-year net earnings per share growth for the last 12 months arcusbio.com (RCUS)|Year-over-year earnings per share growth for the last twelve months Zymeworks Inc (ZYME)|Year-over-year net earnings per share growth for the last 12 months Tango Pharma TNGX|Iovance Biotherapeutics Inc - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Immatics Biotechnologies IMTX|XNCR - Year-over-year earnings per share growth for the last twelve months|CMPX (compasstherapeutics.com) - Year-over-year earnings per share growth for the last 12 months|Replimune Inc. (REPL) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Lyell Immunopharma Inc (LYEL)|Year-over-year net earnings per share growth for the last 12 months IPHA|PYXS - Net earnings per share growth for the trailing year|Year-over-year net earnings per share growth for the last 12 months CGEN (Compugen Ltd.)|Year-over-year earnings per share growth rate for the last twelve months IOBT|Quarterly EPS earnings growth STRO (Sutro Biopharma)|Year-over-year earnings per one share growth for the last 12 months INKT|Werewolf - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Immix Biopharma|ALX Oncology (ALXO) - Year-over-year earnings per share growth for the last twelve months|cuebiopharma.com (CUE) - Quarterly EPS earnings growth|PDSB (PDS Biotechnology Corp) - Quarterly EPS earnings growth|Quarterly EPS earnings growth sonnetbio.com|Year-over-year earnings per share growth for the last twelve months MAIA Biotechnology, Inc. (MAIA)|LIMN: Year-over-year net earnings per share trend for the last twelve months|LAVA Therapeutics - Year-over-year net earnings per share growth for the last 12 months|nextcure.com (NXTC) - Earnings per share growth in annualized terms for the last twelve months|LPTX - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Intensity Therapeutics, Inc. INTS|SNSE: Quarterly EPS earnings growth|Synthetic Biologics - Year-over-year earnings per one share growth for the last 12 months|GRTS (Gritstone bio) - Quarterly EPS earnings growth|KA (Kineta, Inc.) - Year-over-year earnings per share growth rate for the last twelve months|Year-over-year earnings per share growth for the last twelve months Turnstone Biologics Corporation (TSBX)|Year-over-year net earnings per share growth for the last 12 months Vaccinex VCNX|Year-over-year earnings per share growth for the last twelve months harpoontx.com HARP